Virotherapy as potential adjunct therapy for graft-vs-host disease
NY Villa, G McFadden - Current Pathobiology Reports, 2018 - Springer
Abstract Purpose of Review This review discusses the pathophysiology, risk factors, and the
advances in the prevention or treatment of graft-vs-host disease (GvHD) by exploiting …
advances in the prevention or treatment of graft-vs-host disease (GvHD) by exploiting …
Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced …
A Poloni, D Sartini, M Emanuelli, S Trappolini… - Cytokine, 2011 - Elsevier
There are no reliable markers useful to predict the onset or the evolution of chronic graft-
versus-host disease (cGVHD) after allogeneic hematopoietic stem cell transplantation …
versus-host disease (cGVHD) after allogeneic hematopoietic stem cell transplantation …
Initial dosage optimization of ciclosporin in pediatric Chinese patients who underwent bone marrow transplants based on population pharmacokinetics
X Chen, X Yu, DD Wang, H Xu… - Experimental and …, 2020 - spandidos-publications.com
Bone marrow transplants (BMT) are an established therapeutic strategy for patients with
severe aplastic anemia, acute lymphoblastic leukemia, acute myeloid leukemia or chronic …
severe aplastic anemia, acute lymphoblastic leukemia, acute myeloid leukemia or chronic …
Pretransplant donor and recipient CTLA-4 mRNA and protein levels as a prognostic marker for aGvHD in allogeneic hematopoietic stem cell transplantation
L Karabon, M Markiewicz, A Kosmaczewska… - Immunology …, 2015 - Elsevier
Background Cytotoxic T lymphocyte antigen-4 (CTLA-4) is an inhibitory T cells' receptor
essential for maintaining T cell homeostasis and immunotolerance. The role of the co …
essential for maintaining T cell homeostasis and immunotolerance. The role of the co …
[HTML][HTML] Higher numbers of blood CD14+ cells before starting conditioning regimen correlate with greater risk of acute graft-versus-host disease in allogeneic stem cell …
M Arpinati, G Chirumbolo, Y Saunthararajah… - Biology of Blood and …, 2007 - Elsevier
Host antigen-presenting cells (APCs) have been shown to induce acute graft-versus-host
disease (aGVHD) in experimental models. In this study, we investigated whether …
disease (aGVHD) in experimental models. In this study, we investigated whether …
[HTML][HTML] Profile of toll-like receptors on peripheral blood cells in relation to acute graft-versus-host disease after allogeneic stem cell transplantation
C Skert, M Fogli, S Perucca, E Garrafa… - Biology of Blood and …, 2013 - Elsevier
Toll-like receptors (TLRs) play a key role in the cross-talk between the innate and adaptive
immune systems. Previous studies investigating associations between certain TLRs and …
immune systems. Previous studies investigating associations between certain TLRs and …
Extracorporeal photopheresis versus standard treatment for acute graft‐versus‐host disease after haematopoietic stem cell transplantation in paediatric patients
M Weitz, B Strahm, JJ Meerpohl… - Cochrane Database …, 2015 - cochranelibrary.com
Background Acute graft‐versus‐host disease (aGvHD) is a major cause of morbidity and
mortality after haematopoietic stem cell transplantation (HSCT) occurring in 8% to 59% of …
mortality after haematopoietic stem cell transplantation (HSCT) occurring in 8% to 59% of …
[HTML][HTML] A possible association between the presence of interleukin-4–secreting cells and a reduction in the risk of acute graft-versus-host disease
M Takabayashi, H Kanamori, H Takasaki… - Experimental …, 2005 - Elsevier
OBJECTIVE: We monitored cytokine-secreting cells using an enzyme-linked immunospot
(ELISPOT) assay in a prospective study to assess the cytokine network after transplantation …
(ELISPOT) assay in a prospective study to assess the cytokine network after transplantation …
CMV-specific T cell isolation from G-CSF mobilized peripheral blood: depletion of myeloid progenitors eliminates non-specific binding of MHC-multimers
L Beloki, M Ciaurriz, C Mansilla, A Zabalza… - Journal of Translational …, 2014 - Springer
Abstract Background Cytomegalovirus (CMV)-specific T cell infusion to
immunocompromised patients following allogeneic Hematopoietic Stem Cell …
immunocompromised patients following allogeneic Hematopoietic Stem Cell …